United States · FDA National Drug Code directory
TOBI Podhaler
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49502-401_20d6d1c8-8974-4166-b224-d3b7e0c202d6
- Product NDC
- 49502-401
- Form
- CAPSULE
- Composition / generic term
- Tobramycin
- Labeler
- Viatris Specialty LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210901
- Source listing expiry
- 20271231
Source-listed ingredients
- TOBRAMYCIN — 28 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) · 49502-401-09
- 4 PACKAGE in 1 BOX, UNIT-DOSE (49502-401-24) / 7 BLISTER PACK in 1 PACKAGE / 8 CAPSULE in 1 BLISTER PACK · 49502-401-24
- 7 BLISTER PACK in 1 BOX, UNIT-DOSE (49502-401-57) / 8 CAPSULE in 1 BLISTER PACK · 49502-401-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →